A Closer Look at RA Treatment: Targeted DMARDs - a podcast by Clinical Care Options

In this episode, Dr. Stanley Cohen, Dr. Sheetal Desai, and Dr. Eric Ruderman discuss the recent changes in rheumatoid arthritis treatment options, reviewing the landscape of targeted DMARDs and JAK inhibitors, including:

• Kinase signaling
• JAK inhibitor activity and signaling
• JAK selectivity

Presenters:

Stanley B. Cohen, MD
Clinical Professor 
Department of Internal Medicine
University of Texas Southwestern Medical School
Co-Director
Division of Rheumatology
Presbyterian Hospital
Co-Medical Director
Metroplex Clinical Research Center
Dallas, Texas 

Sheetal Desai, MD, MSEd
Chief of Rheumatology
Program Director
University of California, Irvine
Irvine, California

Eric M. Ruderman, MD
Professor, Associate Chief
Division of Rheumatology
Northwestern University Feinberg School of Medicine
Clinical Practice Director
Northwestern Medical Group
Chicago, Illinois

Download the accompanying slides at:
https://bit.ly/3447Gce

See the interactive video at:
https://bit.ly/3oCOtpV

Further episodes of CCO Medical Specialties Podcast

Further podcasts by Clinical Care Options

Website of Clinical Care Options